Supernus Pharmaceuticals, Inc. (SUPN)
SUPN · Pharmaceutical Preparations · Rockville, MD · filing with the SEC since 2006
Grade5.9
◀ Past 5.2● Present 7.1▶ Future 5.0
Filings
378 filings since 2017 beside 483 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026Due nextLarge accelerated filer
10-K
Annual report for the fiscal year ending Dec 31, 2026Large accelerated filers have 60 days after the fiscal year ends.
by Mar 1, 2027
10-Q
Quarterly report for the quarter ending Mar 31, 2027Large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end.
by May 10, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 29 days after the quarter ended. The proxy statement was last filed Apr 30, 2026.
Filings a yearinsider forms included
49666069106113132129
2026 counts to Nov 13, 2026.
Listing warning from its exchange (8-K item 3.01): 1 time in the last 36 months, the newest Nov 2, 2026.Officer or director change (8-K item 5.02): 7 times in the last 36 months, the newest Aug 3, 2026.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Nov 2, 2026
8-K items 1.01, 2.01, 2.03, 3.03, 5.01, 5.03, 7.01, 9.01
Major agreement signed; Purchase or sale of a business completed; New debt or obligation taken on; Change to shareholders' rights; Change of control; Charter, bylaw or fiscal-year change; Investor disclosure (Regulation FD) · Current report
Aug 3, 2026
8-K items 1.01, 5.02, 8.01, 9.01
Major agreement signed; Officer or director change; Other event · Current report
Aug 1, 2026
40 of 378 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.